GLP-1 y el cáncer de mama: un enfoque revolucionario en la lucha contra el cancer
GLP-1 receptor agonists, originally developed for diabetes, show promise in breast cancer research through metabolic pathway modulation, according to a June 2026 analysis. This potential links obesity-related risk factors to ... Read More